Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Wang

Showing results (461-470 of 486) with videos related to

Pageof 49
Sort By:
Diabetes|June 24, 2016
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 ActivationLiping Xie, Yue Gu, Mingliang Wen, et al.
International Journal of Molecular Sciences|May 28, 2020
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma PredictorLeona Osawa, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Scientific Reports|July 14, 2019
Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver diseaseNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 13, 2018
Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infectionYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovirNobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, et al.
Journal of Medical Virology|January 30, 2020
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis BNobuharu Tamaki, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Cancers|August 30, 2019
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular CarcinomaHitomi Takada, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Emerging Microbes & Infections|October 28, 2021
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infectionEncheng Sun, Lianyu Huang, Xianfeng Zhang, et al.
Pageof 49

Showing results (461-470 of 486) with videos related to

Sort By:
Pageof 49
Diabetes|June 24, 2016
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 ActivationLiping Xie, Yue Gu, Mingliang Wen, et al.
International Journal of Molecular Sciences|May 28, 2020
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma PredictorLeona Osawa, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Scientific Reports|July 14, 2019
Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver diseaseNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 13, 2018
Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infectionYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovirNobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, et al.
Journal of Medical Virology|January 30, 2020
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis BNobuharu Tamaki, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Cancers|August 30, 2019
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular CarcinomaHitomi Takada, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Emerging Microbes & Infections|October 28, 2021
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infectionEncheng Sun, Lianyu Huang, Xianfeng Zhang, et al.
Pageof 49